The Hopen team consists of experienced professionals with diverse life science backgrounds in research and development, operations, marketing, clinical trials, business development, finance, and patient care.  Members of the team have led significant life science public offerings, successfully closed and integrated more than 25 acquisitions, and completed in excess of 50 technology alliances and joint ventures.

Mark Olesnavage
Mark Olesnavage
Managing Director
Michael Fulton, MD
Michael Fulton, MD
Managing Director
Douglas Morton, PhD
Douglas Morton, PhD
Scientific and Medical Advisory Board Chair
Michael Jandernoa
Michael Jandernoa
Managing General Partner
William Baer, MD, PharmD
William Baer, MD, PharmD
Scientific and Medical Advisory Board
Dan Hartman, MD, FCCP
Dan Hartman, MD, FCCP
Scientific and Medical Advisory Board
W. Gary Tarpley, PhD
W. Gary Tarpley, PhD
Scientific and Medical Advisory Board
Jerry Callahan
Jerry Callahan, PhD
Venture Partner
Tom
Thomas Buschert, CPA
Chief Financial Officer
Nate Fredrickson
Nathan Fredrickson
Associate